DUNAD THERAPEUTICS
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
DUNAD THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2020-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.dunad.co.uk
Status:
Active
Total Funding:
24 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS DMARC Digital Ocean Elastic Email
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.
MRM Health NV
MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Conor Scully Associate Director, Computational Chemistry @ Dunad Therapeutics
Associate Director, Computational Chemistry
2022-01-01
Pearl Huang CEO @ Dunad Therapeutics
CEO
2022-06-01
Diana Kraskouskaya Chief Operating Officer & Co-founder @ Dunad Therapeutics
Chief Operating Officer & Co-founder
2020-01-01
Patrick T. Gunning Co-Founder and Chief Scientific Officer @ Dunad Therapeutics
Co-Founder and Chief Scientific Officer
2021-03-01
Founder
Investors List
Novartis
Novartis investment in Series A - Dunad Therapeutics
Epidarex Capital
Epidarex Capital investment in Series A - Dunad Therapeutics
BioGeneration Ventures
BioGeneration Ventures investment in Series A - Dunad Therapeutics
Epidarex Capital
Epidarex Capital investment in Seed Round - Dunad Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-28 | Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive Officer |
Official Site Inspections
http://www.dunad.co.uk Semrush global rank: 4.4 M Semrush visits lastest month: 2.54 K
- Host name: 764520.cloudwaysapps.com
- IP address: 209.97.186.50
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Dunad Therapeutics"
UK biotech Dunad inks $1.3bn Novartis deal for its …
3 days ago In only its second year of operations, Cambridge, UK startup Dunad Therapeutics has already attracted a big pharma partner for its protein …See details»
Dunad Therapeutics - Crunchbase Company Profile
Organization. Dunad Therapeutics . Connect to CRM . Save . Summary. …See details»
Dunad Therapeutics | Developing Transformational Therapies with …
Dunad Therapeutics combines proprietary, tunable covalent chemistry with a deep understanding of disease biology to discover and develop transformational medicines that selectively and …See details»
Dunad Therapeutics enters Strategic Collaboration with Novartis …
CAMBRIDGE, England, Nov. 2, 2021 /PRNewswire/ -- Dunad Therapeutics ("Dunad"), a biopharmaceutical company focusing on the development of next-generation targeted protein …See details»
Dunad Therapeutics
Nov 24, 2024 In 2021, Dunad entered a strategic collaboration with Novartis to develop next-generation therapies in a deal worth $24 million in an upfront payment with equity investment …See details»
DUNAD Therapeutics Emerges to Develop Next-Generation Small …
Mar 23, 2021 New UK company backed by Epidarex Capital emerges from stealth. Cambridge, UK, March 23, 2021 – Dunad Therapeutics (“Dunad”) emerges today to develop next …See details»
BGV portfolio company Dunad Ltd announces $1.3B strategic …
Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and …See details»
Dunad Therapeutics – Startups.Bio
Mar 25, 2021 Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, …See details»
DUNAD THERAPEUTICS LTD. - Companies House
Charges for DUNAD THERAPEUTICS LTD. (12544797) Registers for DUNAD THERAPEUTICS LTD. (12544797) More for DUNAD THERAPEUTICS LTD. (12544797) Registered office …See details»
Dunad Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Dunad Therapeutics. Join to edit. Join to edit. Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation …See details»
Dunad Therapeutics enters strategic collaboration with Novartis
Nov 3, 2021 Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally …See details»
Dalriada Drug Discovery Celebrates Client Dunad Therapeutics …
Nov 4, 2021 Since its inception Dunad's R&D has been supported by Dalriada, a contract research organization to enable the development of their novel therapeutic modality that uses …See details»
Novartis Links with UK's Dunad in $1.3 Billion Protein ... - BioSpace
Nov 2, 2021 Harold Cunningham/Getty Images. Novartis has forged a collaboration with U.K.-startup Dunad Therapeutics to develop next-generation targeted protein-degradation therapies …See details»
Dunad | BioGeneration Ventures
Dunad Therapeutics focuses on the development of next-generation targeted protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using …See details»
Dunad Therapeutics - workinbiotech.com
Dunad Therapeutics develops next-generation small-molecule protein degradation therapies through use of their proprietary screening library and mono-valent degrader platform. Their …See details»
Dunad Therapeutics Appoints Michael Bonney as Chair of Board of ...
Jan 9, 2023 Dunad Therapeutics is a biopharmaceutical company with operations in Cambridge, England and Cambridge, Massachusetts developing covalent small molecule therapies based …See details»
Dunad Therapeutics - Funding, Financials, Valuation & Investors
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies. New. Resources. ... How much funding has …See details»
Dunad: Expanding protein degradation beyond E3 ligase
Mar 24, 2021 Dunad has emerged from a year in stealth with a platform that the U.K. company believes could offer a simpler mechanism for degrading protein targets. One of the primary …See details»
Diana Kraskouskaya - Chief Operating Officer & Co-founder
Diana, a co-founder and Chief Operating Officer of Dunad, brings to the Dunad team years of leadership and hands-on cross-disciplinary biotech experience spanning areas of company …See details»
Patrick T. Gunning - Co-Founder and Chief Scientific Officer
Patrick T. Gunning is the Co-Founder and CSO of Dunad Therapeutics. He previously worked at Yale University as a Postdoctoral Research Associate. Patrick T. Gunning attended the …See details»